Innovations in Tobacco Control Lecture Series: Anna Gilmore
Innovations in Tobacco Control Lecture Series | Guest Lecturer
Anna Gilmore, PhD, discusses how commercial entities impact human and planetary health and what can be done to address it during this lecture presented by the Institute for Global Tobacco Control
For more information, visit the event page:
https://qa.publichealth.jhu.edu/node/306366.
Johns Hopkins Bloomberg School of Public Health 2024-11-06 14:30 2024-11-06 15:30 UTC use-title Location Zoom
About the Event
Hosted by the Institute for Global Tobacco Control (IGTC), the monthly Innovations in Tobacco Control lecture series welcomes key researchers and experts to share ideas, present their work, and spark discussion. Presented via Zoom, this month’s event welcomes Anna Gilmore, PhD, for a lecture entitled “Commercial Determinants of Health.”
The lecture will be followed by a brief moderated Q&A and a recording of the event will subsequently be posted to IGTC’s YouTube channel.
Registration
Upon approval of online registration, attendees will receive a personalized Zoom link to access the webinar.
Speaker
Anna Gilmore, PhD
University of Bath
A clinician by background, Anna Gilmore is professor of public health, founding director of the Tobacco Control Research Group, and co-director of the Centre for 21st Century Public Health at the University of Bath. Her work focuses on the commercial determinants of health and evaluates the impacts of public policies on health. It has led to policy impacts at both the local and global levels, recognized through numerous awards including the WHO World No Tobacco Day Medal (2008), Public Health Advocacy Institute Award (2009), and the inaugural European Health Leadership Award (2019) for “pioneering change makers.” In 2012, her team established the ground-breaking knowledge exchange platform TobaccoTactics.org and, in 2018, became the research partner in STOP, a global tobacco industry watchdog. Anna has over 300 publications and is a member of various international and national expert groups including the WHO’s recently established international expert group on the Commercial Determinants of Health.